Sequence Summary Report
Sequence name: 20220201aciclov 2022-02-01 17-40-54
Instrument_Name AGILENT II Injection_AcqMethodName ACICLOVIR.M
Acquisition date: 2/1/2022 5:40:54 PM Acquired by: ADMINISTRADOR
Data path: C:\Chem32\1\Data\20220201aciclovirung\20220201aciclov 2022-02-01 17-40-54
Signal_Description DAD1 A, Sig=254,4 Ref=off Injection_ColumnLength 250.000
Injection_ColumnName Chromanik -C18 Injection_ColumnSerialNo autoID-80
Column, 4.6 x 150mm,
5um
Injection_ColumnDiameter 4.600 Injection_Volume 20.000
REP ESTAB N.rdl [Rev. 181] Printed: 2/2/2022 8:04:39 AM
Sequence Summary Report
REP ESTAB N.rdl [Rev. 181] Printed: 2/2/2022 8:04:39 AM
Sequence Summary Report
Sample_Name ESTANDAR DE
ACICLOVIR LOTE
R124M0
Name RT Sample Name Area Height Amount Unit Sampl Peak Peak
e Vial Theoret Symme
Numbe ical try
r Plates
USP
aciclovir 14.710 ESTANDAR DE 4840.4448 232.5285 1.000 mg/ml 54 11499.7 0.98
ACICLOVIR
LOTE R124M0
aciclovir 14.637 ESTANDAR DE 4839.7090 232.7814 1.000 mg/ml 54 11446.7 0.97
ACICLOVIR
LOTE R124M0
aciclovir 14.627 ESTANDAR DE 4843.2275 234.1543 1.000 mg/ml 54 11572.5 0.97
ACICLOVIR
LOTE R124M0
aciclovir 14.609 ESTANDAR DE 4847.9458 234.6065 1.001 mg/ml 54 11604.8 0.96
ACICLOVIR
LOTE R124M0
aciclovir 14.598 ESTANDAR DE 4850.2285 235.3873 1.001 mg/ml 54 11636.5 0.96
ACICLOVIR
LOTE R124M0
REP ESTAB N.rdl [Rev. 181] Printed: 2/2/2022 8:04:39 AM
Sequence Summary Report
Approved by:
Signature:
Date:
REP ESTAB N.rdl [Rev. 181] Printed: 2/2/2022 8:04:39 AM